AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $8 | $7 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $11 | $8 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $18 | $17 | $12 |
| Total Curr. Assets | $14 | $37 | $32 | $17 |
| Property Plant & Equip (Net) | $24 | $27 | $28 | $28 |
| Goodwill | $0 | $0 | $0 | $13 |
| Intangibles | $1 | $1 | $1 | $10 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $27 | $29 | $30 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $66 | $61 | $68 |
| Liabilities | – | – | – | – |
| Payables | $2 | $5 | $3 | $4 |
| Short-Term Debt | $6 | $1 | $7 | $11 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $5 | $4 | $5 | $4 |
| Other Curr. Liab. | $29 | $45 | $22 | $24 |
| Total Curr. Liab. | $42 | $56 | $37 | $44 |
| LT Debt | $7 | $8 | $8 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $2 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $8 | $9 | $9 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $50 | $65 | $46 | $54 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $3 | $3 | $2 |
| Retained Earnings | -$578 | -$546 | -$524 | -$490 |
| AOCI | $4 | $3 | $4 | $5 |
| Other Equity | $554 | $537 | $527 | $492 |
| Total Equity | -$14 | -$3 | $11 | $8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $5 | $5 | $6 |
| Total Liab. & Tot. Equity | $40 | $66 | $61 | $68 |
| Net Debt | $10 | $1 | $8 | $18 |